English

NephroGenex, Inc.

EDGAR

Annual report (10-K) · filed 2016-03-29

13 filing records in this dataset, filed from 2013-12-23 to 2016-03-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 18.8 million USD 2015-12-31 Source
Exact value

18830000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 12.9 million shares 2015-12-31 Source
Exact value

12946018 shares

Reported share-count change

46.08% · 4.08 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

8862114 shares · 2014-12-31· Source
12946018 shares · 2015-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-22.9 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Net income: -5173000 USD · 2015-01-01 – 2015-03-31 Source
Net income: -6379000 USD · 2015-04-01 – 2015-06-30 Source
Net income: -5347000 USD · 2015-07-01 – 2015-09-30 Source
Net income: -22864000 USD · 2015-01-01 – 2015-12-31 Source
Net income: -16899000 USD · 2015-01-01 – 2015-09-30 Source

Operating cash flow

-19.6 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Operating cash flow: -4673000 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -9701000 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -4673000 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -15733000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -9701000 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -19635000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -15733000 USD · 2015-01-01 – 2015-09-30 Source

Capital expenditure

16 thousand USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Capital expenditure: 8000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 10000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 8000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 16000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 10000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 16000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 16000 USD · 2015-01-01 – 2015-09-30 Source

Free cash flow

-19.7 million USD

2015-01-01 – 2015-12-31

Exact inputs and evidence

Operating cash flow: -4673000 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -9701000 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -4673000 USD · 2015-01-01 – 2015-03-31 Source
Operating cash flow: -15733000 USD · 2015-01-01 – 2015-09-30 Source
Operating cash flow: -9701000 USD · 2015-01-01 – 2015-06-30 Source
Operating cash flow: -19635000 USD · 2015-01-01 – 2015-12-31 Source
Operating cash flow: -15733000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 8000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 10000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 8000 USD · 2015-01-01 – 2015-03-31 Source
Capital expenditure: 16000 USD · 2015-01-01 – 2015-09-30 Source
Capital expenditure: 10000 USD · 2015-01-01 – 2015-06-30 Source
Capital expenditure: 16000 USD · 2015-01-01 – 2015-12-31 Source
Capital expenditure: 16000 USD · 2015-01-01 – 2015-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2016-03-29.

Financial data available through: 2015-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 3 of 11 periods available· newest 2015-12-31
Net income: 11 of 11 periods available· newest 2015-12-31
Operating cash flow: 3 of 11 periods available· newest 2015-12-31
Capital expenditure: 3 of 11 periods available· newest 2015-12-31
Total assets: 3 of 11 periods available· newest 2015-12-31
Total liabilities: 3 of 11 periods available· newest 2015-12-31
Current assets: 3 of 11 periods available· newest 2015-12-31
Current liabilities: 3 of 11 periods available· newest 2015-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2015-12-31
long term debt: No compatible figures in this window
Shares outstanding: 3 of 11 periods available· newest 2015-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 6.04 million

Prior period

−USD 16.82 million

2014-01-01 – 2014-12-31
Current period

−USD 22.86 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-22864000 − -16820000 = -6044000 USD

-16820000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-22864000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Year-over-year change in Net income: -6044000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -22864000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160697 Filing: 000133809516000103 Input fundies:NetIncome: -16820000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160320 Filing: 000133809516000103
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 6 million

Prior period

−USD 13.64 million

2014-01-01 – 2014-12-31
Current period

−USD 19.64 million

2015-01-01 – 2015-12-31

Exact inputs and evidence

-19635000 − -13638000 = -5997000 USD

-13638000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
-19635000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Year-over-year change in Operating cash flow: -5997000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -19635000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160068 Filing: 000133809516000103 Input fundies:OperatingCashFlow: -13638000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#159816 Filing: 000133809516000103
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-44.8%

Prior period

USD 29,000

2014-01-01 – 2014-12-31
Current period

USD 16,000

2015-01-01 – 2015-12-31

Exact inputs and evidence

16000 − 29000 = -13000 USD

29000 USD · 2014-01-01 – 2014-12-31
Inspect prior input Prior source
16000 USD · 2015-01-01 – 2015-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Year-over-year change in Capital expenditure: -13000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 16000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#170323 Filing: 000133809516000103 Input fundies:CapitalExpenditure: 29000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#170115 Filing: 000133809516000103
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 1.34 million Exact value Exact value: -1337715 USD 2006-01-01 – 2006-12-31: -1337715 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2006-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -1337715 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1337715 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#133325 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 7.57 million Exact value Exact value: -7570642 USD 2007-01-01 – 2007-12-31: -7570642 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2007-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -7570642 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7570642 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#133441 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 6.74 million Exact value Exact value: -6740834 USD 2008-01-01 – 2008-12-31: -6740834 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2008-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -6740834 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6740834 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#133720 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 7.55 million Exact value Exact value: -7549788 USD 2009-01-01 – 2009-12-31: -7549788 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2009-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -7549788 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7549788 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#133999 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 5.92 million Exact value Exact value: -5920765 USD 2010-01-01 – 2010-12-31: -5920765 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2010-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -5920765 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5920765 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#134278 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2011 2011-01-01 – 2011-12-31	−USD 1.85 million Exact value Exact value: -1851797 USD 2011-01-01 – 2011-12-31: -1851797 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2011-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -1851797 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1851797 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#134557 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 2.9 million Exact value Exact value: -2904164 USD 2012-01-01 – 2012-12-31: -2904164 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2012-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -2904164 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2904164 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000110465914038337/nrx-20140331.xml#121936 Filing: 000110465914038337 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2013 2013-01-01 – 2013-12-31	−USD 6.31 million Exact value Exact value: -6305000 USD 2013-01-01 – 2013-12-31: -6305000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2013-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -6305000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6305000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809515000016/nrx-20141231.xml#140217 Filing: 000133809515000016 The citation records this snapshot. The page link may show a newer release later.	−USD 2.71 million Exact value Exact value: -2712000 USD 2013-01-01 – 2013-12-31: -2712000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NephroGenex, Inc. · 2013-12-31 NephroGenex, Inc. (edgar:1338095) Operating Cash Flow: -2712000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2712000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809515000016/nrx-20141231.xml#139714 Filing: 000133809515000016 The citation records this snapshot. The page link may show a newer release later.	USD 12,000 Exact value Exact value: 12000 USD 2013-01-01 – 2013-12-31: 12000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NephroGenex, Inc. · 2013-12-31 NephroGenex, Inc. (edgar:1338095) Capital Expenditure: 12000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809515000016/nrx-20141231.xml#148203 Filing: 000133809515000016 The citation records this snapshot. The page link may show a newer release later.	−USD 2.72 million Calculation and evidence -2712000 − 12000 USD Exact free cash flow: -2724000 USD 2013-01-01 – 2013-12-31: -2712000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 12000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NephroGenex, Inc. · 2013-12-31 NephroGenex, Inc. (edgar:1338095) Free cash flow: -2724000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2712000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809515000016/nrx-20141231.xml#139714 Filing: 000133809515000016 Input fundies:CapitalExpenditure: 12000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809515000016/nrx-20141231.xml#148203 Filing: 000133809515000016 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 16.82 million Exact value Exact value: -16820000 USD 2014-01-01 – 2014-12-31: -16820000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2014-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -16820000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16820000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160320 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.	−USD 13.64 million Exact value Exact value: -13638000 USD 2014-01-01 – 2014-12-31: -13638000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NephroGenex, Inc. · 2014-12-31 NephroGenex, Inc. (edgar:1338095) Operating Cash Flow: -13638000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13638000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#159816 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.	USD 29,000 Exact value Exact value: 29000 USD 2014-01-01 – 2014-12-31: 29000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NephroGenex, Inc. · 2014-12-31 NephroGenex, Inc. (edgar:1338095) Capital Expenditure: 29000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#170115 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.	−USD 13.67 million Calculation and evidence -13638000 − 29000 USD Exact free cash flow: -13667000 USD 2014-01-01 – 2014-12-31: -13638000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 29000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NephroGenex, Inc. · 2014-12-31 NephroGenex, Inc. (edgar:1338095) Free cash flow: -13667000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13638000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#159816 Filing: 000133809516000103 Input fundies:CapitalExpenditure: 29000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#170115 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 22.86 million Exact value Exact value: -22864000 USD 2015-01-01 – 2015-12-31: -22864000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Net Income: -22864000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -22864000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160697 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.	−USD 19.64 million Exact value Exact value: -19635000 USD 2015-01-01 – 2015-12-31: -19635000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Operating Cash Flow: -19635000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19635000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160068 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.	USD 16,000 Exact value Exact value: 16000 USD 2015-01-01 – 2015-12-31: 16000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Capital Expenditure: 16000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#170323 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.	−USD 19.65 million Calculation and evidence -19635000 − 16000 USD Exact free cash flow: -19651000 USD 2015-01-01 – 2015-12-31: -19635000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 16000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NephroGenex, Inc. · 2015-12-31 NephroGenex, Inc. (edgar:1338095) Free cash flow: -19651000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:00:11Z Snapshot: cbf133336a7f9ac915bd203d2503ffc06c80fe4ca061f4a988fef601c291cc0f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1338095?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19635000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#160068 Filing: 000133809516000103 Input fundies:CapitalExpenditure: 16000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1338095/000133809516000103/nrx-20151231.xml#170323 Filing: 000133809516000103 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

13 filings · 478 latest values · 478 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001338095, 1338095, edgar:1338095

Also known as NephroGenex Inc, NephroGenex, Inc.

NephroGenex, Inc.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation